Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
DC Ziogas, C Theocharopoulos, T Koutouratsas… - Cancer Treatment …, 2023 - Elsevier
Marching into the second decade after the approval of ipilimumab, it is clear that immune
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
DC Ziogas, C Theocharopoulos… - Cancer treatment …, 2023 - pubmed.ncbi.nlm.nih.gov
Marching into the second decade after the approval of ipilimumab, it is clear that immune
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
DC Ziogas, C Theocharopoulos… - Cancer …, 2023 - cancertreatmentreviews.com
Marching into the second decade after the approval of ipilimumab, it is clear that immune
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
DC Ziogas, C Theocharopoulos… - Cancer Treatment …, 2022 - europepmc.org
Marching into the second decade after the approval of ipilimumab, it is clear that immune
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …
checkpoint inhibitors (ICIs) have dramatically improved the prognosis of melanoma …